Ayesha Patil

Dr. Ayesha Patil

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2022 in Vision
Verified
Journal Article
Open access
PDF file
APAyesha Patil
Ayesha Patil
CSCole Swiston
Cole Swiston
RWRyan T Wallace
Ryan T Wallace
CPChase Paulson
Chase Paulson
MCMatthew E. Conley
Matthew E. Conley
BWBarbara M. Wirostko
Barbara M. Wirostko
(1) Background: Exfoliation syndrome (XFS) is a common cause of secondary open angle glaucoma. In 1971, Faulkner et al. estimated the prevalence of XFS among 50 Navajo Nation residents as 38%. Given that XFS can cause irreversible blindness secondary to glaucoma (XFG), this study aims to identify the current prevalence of XFS among Navajo Nation residents within the Four Corners region of the U.S. (2) Methods: A retrospective chart review was conducted from 2016 to 2021 for patients aged 18 and older. All patients with XFS or XFG diagnosed by slit lamp exam were identified through chart review. (3) Results: Of the 1152 patient charts available for review, eight patients (11 eyes) were diagnosed with XFS with three patients (4 eyes) demonstrating concomitant XFG. Within this XFS population, 50% of the patients identified as male, with a mean age of 73 years. The overall prevalence of XFS was 0.7% and the overall prevalence of XFG was found to be 0.26%. The rate of XFG among patients with XFS was 37.5%. (4) Conclusion: Compared to Faulkner’s study of Navajo Nation residents in 1971, our findings show a considerably lower prevalence of XFS at 0.7%. We present the largest study to date of XFS among this population.

8 December 2022 in Acta Ophthalmologica
Verified
Journal Article
Closed access
APAyesha Patil
Ayesha Patil
MCMatthew Conley
Matthew Conley
CPChase Paulson
Chase Paulson
CPChristian Pompoco
Christian Pompoco
RWRyan Wallace
Ryan Wallace
BWBarbara Wirostko
Barbara Wirostko

13 December 2022 in Acta Ophthalmologica
Verified
Journal Article
Closed access
APAyesha Patil
Ayesha Patil
MCMatthew Conley
Matthew Conley
CPChristian Pompoco
Christian Pompoco
CPChase Paulson
Chase Paulson
STSamuel Taylor
Samuel Taylor
BWBarbara Wirostko
Barbara Wirostko

Verified
Journal Article
Open access
PDF file
CPChristian Pompoco
Christian Pompoco
CPChase Paulson
Chase Paulson
NFNora Fino
Nora Fino
STSamuel Taylor
Samuel Taylor
APAyesha Patil
Ayesha Patil
BWBarbara Wirostko
Barbara Wirostko
Objective: To investigate any relationships between exfoliation syndrome or exfoliation glaucoma and age-related macular degeneration utilizing the Utah population database. Design: This was a retrospective, case–control cohort study. Subjects, Participants, and/or Controls: We identified 3405 patients diagnosed with exfoliation syndrome (XFS) or exfoliation glaucoma (XFG) during a dilated eye exam within the UHealth system from 1996 to 2021, whose dry or wet age-related macular degeneration (AMD) status was assessed. A population-based control pool of 257,714 UHealth patients with no XFS/XFG diagnosis and a dilated eye exam history from 1996 to 2021 was compiled, with its patients randomly selected and individually matched 3:1 to cases based on sex and age at index diagnosis of their respective case. Methods: A covariate analysis was performed of characteristics and risk factors associated with XFS/XFG, which included race/ethnicity, residence location, partner/marital status, and family history of XFS/XFG, obesity, tobacco use, alcohol use, osteoporosis/vitamin D deficiency, primary/essential hypertension, ocular hypertension, and cataract surgery. Main Outcome Measure: We studied the trends of non-exudative (dry) or exudative (wet) AMD in a large Utah population study of XFS/XFG patients and controls. Results: Of 3396 XFS/XFG patients, as well as 10,179 individually matched 3:1 control patients, 64% were female and the average age of XFS onset was 74.3 yrs. In a univariate model, we observed a very modest increased risk of wet AMD in XFS/XFG patients (odds ratio, OR = 1.14, 95% confidence interval (CI) 0.99–1.32), which did not achieve statistical significance (p = 0.07). After adjusting for the main effects of potential confounders, there was no greater presentation of AMD in XFS/XFG patients when compared with controls (dry AMD: OR = 0.94, 95% CI 0.85–1.05, p = 031; wet AMD: OR = 0.98, 95% CI 0.83–1.14, p = 0.76). In XFS/XFG patients compared to controls, the risk of having cataract surgery was elevated (OR = 2.39, 95% CI 2.18–2.62). However, after accounting for an interaction with AMD, XFS/XFG patients who underwent cataract surgery did not exhibit an increased risk of either dry or wet AMD (dry AMD: OR = 0.91, 95% CI 0.80–1.03; wet AMD: OR = 0.89, 95% CI 0.75–1.07). The risk of AMD in XFS/XFG patients vs. controls showed no association with osteoporosis/vitamin D deficiency for dry (OR 0.78 95% CI 0.66–0.92 p = 0.004) or wet AMD (OR = 0.72 95% CI 0.56–0.92 p = 0.01), while we found a borderline positive association with both dry and wet AMD if they had osteoporosis/vitamin D deficiency. Conclusion: Using the Utah Population Database, we found that a cataract surgery history significantly impacts the association between AMD and XFS, and that vitamin D deficiency/osteoporosis is a significant confounder of the association. However, no direct association between XFS and AMD was found in this study.

7 November 2024 in Journal of Academic Ophthalmology
Verified
Journal Article
Open access
PDF file
EBEleanor Burton
Eleanor Burton
CPChase Paulson
Chase Paulson
APAyesha Patil
Ayesha Patil
RGRuby Garcia
Ruby Garcia
SJSydni Johnson
Sydni Johnson
RSRachel G. Simpson
Rachel G. Simpson
Importance: Gender equity is an important topic in medicine and accurate trends are essential to evaluate historical, current, and future trends. Objective: To describe changes in gender representation at American Academy of Ophthalmology (AAO) meetings from 2004 to 2019. Participants: Presenters at the American Academy of Ophthalmology meetings from 2004 to 2019. Design & Setting: This is a retrospective cross-sectional study. Data was extracted using AAO annual and subspecialty meeting archives for every third year between 2004 and 2019. Sessions were stratified by category and subspecialty. Poster sessions were excluded. Gender was considered binary and determined using pronouns or photographs from professional websites when available and the gender-api name tool when individual information was not available. Main outcome measures: Proportion of gender of the presenters at the American Academy of Ophthalmology within respective specialties with a focus on surgical vs clinical sessions. Results: The proportion of female presenters at AAO meetings increased between 2004 and 2019 from 13% to 29%. The largest changes were observed for oncology (net +28%, 1.85%/year increase, OR 1.09) and oculoplastics (+25%, 1.66%/year increase, OR 1.106). For surgical sessions, the increase in proportion of female speakers fell short of the overall increase in representation in comprehensive (+16% overall vs. +13% for surgical sessions), glaucoma (11% vs. 7%), and pediatrics (+17% vs. -1%). The increase in female representation among surgical session presenters did not exceed the overall increase for any subspecialty. For clinical sessions, the proportion of female leaders exceeded the overall increase in cornea (20% cornea vs. 13% overall), neuro-ophthalmology (15% vs. 9%), and pediatrics (35% vs. 17%). Conclusions: Female representation among presenters at the AAO annual and subspecialty meetings increased between 2004 and 2019 for all subspecialties. For many subspecialties, there was a proportionally slower rate of increase in female representation among surgical session presenters and faster rate of increase for clinical sessions.